Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05662605 · ClinicalTrials.gov registry record · NA
W-PPMA for Postpartum Mothers
A NA study, sponsored by Woebot Health.
- Terminated
- Registry status
- NA
- Development phase
- 281
- Enrollment target
NCT05662605: Clinical Trial NA study, sponsored by Woebot Health.
NCT05662605 is a NA study that was terminated before completion, run by Woebot Health. The registered enrollment target is 281 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05662605, a NA study, was terminated before completion, sponsored by Woebot Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 281 participants
- Enrollment target
Study Summary
To evaluate the feasibility and acceptability of W-PPMA among a diverse group of postpartum mothers.
Primary Outcome
Measure of feasibility. A 6-item subscale that inquires about factors that impact treatment usage (i.e., intervention quality). Responses range from 1 = "slightly disagree" to 6 = "strongly agree". Scores are averages, with greater scores indicating greater intervention feasibility.
Interventions
- DEVICE W-PPMA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 281 participants |
| Start Date | 2023-02-22 |
| Est. Completion | 2024-03-17 |
| Phase | NA |
Why NCT05662605 stopped before completion
NCT05662605 is an interventional study that assigns participants to a tested intervention. The registered 281 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which W-PPMA is the first listed.
NCT05662605 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05662605 about?
NCT05662605 is a clinical study titled "W-PPMA for Postpartum Mothers". To evaluate the feasibility and acceptability of W-PPMA among a diverse group of postpartum mothers.
What is the current status of trial NCT05662605?
This trial is currently terminated. It is a NA study. The enrollment target is 281 participants. The study started on 2023-02-22. Estimated completion is 2024-03-17.
What interventions are being tested in trial NCT05662605?
The interventions under investigation include: W-PPMA (DEVICE).
Who is sponsoring clinical trial NCT05662605?
This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05662605's enrollment target sits among peer trials
281 380th of 2000 higher than 1,621 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04521231 · 281 participants · Phase 1
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
- NCT06190730 · 281 participants · NA
REmote Symptom COllection to improVE postopeRative Care
- NCT02860364 · 282 participants · NA
Comparing Hypothermic Temperatures During Hemiarch Surgery
- NCT04867395 · 282 participants · NA
A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI